Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl

Blood. 2008 Apr 15;111(8):4064-74. doi: 10.1182/blood-2007-08-107466. Epub 2008 Jan 3.

Abstract

Self-renewal capacity is rapidly lost during differentiation of hematopoietic stem cells to lineage-committed progenitors. We demonstrate here that regulated intracellular signaling through the cytokine receptor Mpl induces profound expansion of not only multipotent (ie, lymphomyeloid) but also lymphoid-committed human hematopoietic progenitors. A fusion protein containing the intracellular signaling domain of Mpl and a dimerization domain was constitutively expressed in populations enriched in human lymphomyeloid progenitor/stem cells (CD34(+)CD38(-)Lin(-)CD7(-)) and multilymphoid progenitors (CD34(+)CD38(-)Lin(-)CD7(+)). Intracellular dimerization of Mpl in target cells was induced by in vitro or in vivo administration of a diffusible synthetic ligand. In vitro, Mpl dimerization produced divisions of clonogenic, multilineage CD34(+) cells able to engraft immunodeficient mice. When dimerization was induced in vivo after transplantation of either lymphomyeloid or multilymphoid progenitors, donor-derived hematopoiesis was sustained for at least 12 weeks and primitive CD34(+)Lin(-) progenitors were expanded more than 1000-fold. Lineage potential of progenitors was not altered and differentiation was not prevented by synthetically induced Mpl signaling. These data demonstrate that dimerization of a single cytokine receptor can deliver a profound expansion signal in both uncommitted and lymphoid-committed human hematopoietic progenitors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD34 / metabolism
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects
  • Cell Division / drug effects
  • Cell Lineage* / drug effects
  • Cell Proliferation / drug effects
  • Dimerization
  • Gene Expression Regulation / drug effects
  • Humans
  • Immunophenotyping
  • Intracellular Space / drug effects
  • Intracellular Space / metabolism*
  • Leukocyte Common Antigens / metabolism
  • Lymphocytes / cytology*
  • Lymphocytes / drug effects
  • Mice
  • Multipotent Stem Cells / cytology*
  • Multipotent Stem Cells / drug effects
  • Receptors, Thrombopoietin / genetics
  • Receptors, Thrombopoietin / metabolism*
  • Recombinant Fusion Proteins / metabolism
  • Signal Transduction / drug effects
  • Stem Cell Transplantation
  • Tacrolimus / analogs & derivatives
  • Tacrolimus / pharmacology
  • Transduction, Genetic
  • Umbilical Cord / cytology
  • Umbilical Cord / drug effects

Substances

  • AP20187
  • Antigens, CD34
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • MPL protein, human
  • Leukocyte Common Antigens
  • Tacrolimus